Association of the Oestrogen Receptor Alpha Gene Polymorphisms with Disease Onset in Systemic Lupus Erythematosus

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 2004 Sep 14

PMID 15361380

Citations 23

Authors

Y J Lee

K S Shin

S W Kang

C K Lee

B Yoo

H S Cha

E M Koh

S J Yoon

J Lee

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate the genetic influence of PvuII and XbaI polymorphisms of oestrogen receptor alpha (ORalpha) in patients with systemic lupus erythematosus (SLE) in Korea.

Methods: Genomic DNA from 268 female controls and 137 female SLE patients (41 childhood onset and 96 adult onset) were analysed using PvuII and XbaI restriction fragment length polymorphism. Comparison of the frequencies of alleles and genotypes was made in control and patient groups and in childhood onset and adult onset SLE subgroups.

Results: Although the Pp genotype occurred more often in SLE patients than in controls (p(c) = 0.017), ORalpha genotype distributions of adult onset SLE did not differ significantly from controls. The PP, Pp, and xx genotypes occurred less often in childhood onset SLE (p(c) = 0.0045, 0.0498, and 0.0255, respectively) than in controls. Additionally, the PP genotype was less common in childhood onset than in adult onset SLE (p(c) = 0.016). SLE patients with the PP genotypes were older at disease onset than those with the other genotypes (p = 0.001). Patients with the Xx genotype had an earlier onset of SLE than those with the xx genotype (p = 0.025). The frequency of the combined ppXx genotype was greater in childhood onset SLE than in controls (p(c) = 0.0009) or adult onset SLE (p(c) = 0.027). The same trend was supported by subgroup analyses according to age at menarche and logistic multivariate analyses.

Conclusions: ORalpha polymorphisms are significantly associated with the age at disease onset in Koreans with SLE.

Citing Articles

Construction of competing endogenous RNA networks in systemic lupus erythematosus by integrated analysis.

He J, Dai Y, Liu J, Lin H, Gao F, Chen Z Front Med (Lausanne). 2024; 11:1383186.

PMID: 38835801 PMC: 11149421. DOI: 10.3389/fmed.2024.1383186.

Systemic Lupus Erythematosus in Children and Young People.

Charras A, Smith E, Hedrich C Curr Rheumatol Rep. 2021; 23(3):20.

PMID: 33569643 PMC: 7875946. DOI: 10.1007/s11926-021-00985-0.

Estrogen Receptor Alpha Signaling Is Responsible for the Female Sex Bias in the Loss of Tolerance and Immune Cell Activation Induced by the Lupus Susceptibility Locus .

Graham J, Yoachim S, Gould K Front Immunol. 2020; 11:582214.

PMID: 33240270 PMC: 7683613. DOI: 10.3389/fimmu.2020.582214.

Sex Hormones in Acquired Immunity and Autoimmune Disease.

Moulton V Front Immunol. 2018; 9:2279.

PMID: 30337927 PMC: 6180207. DOI: 10.3389/fimmu.2018.02279.

Clinical implications of systemic lupus erythematosus without and with antiphospholipid syndrome in peri- and postmenopausal age.

Grygiel-Gorniak B, Limphaibool N, Puszczewicz M Prz Menopauzalny. 2018; 17(2):86-90.

PMID: 30150916 PMC: 6107090. DOI: 10.5114/pm.2018.77308.

References

Tucker L, Menon S, Schaller J, Isenberg D . Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol. 1995; 34(9):866-72. DOI: 10.1093/rheumatology/34.9.866. View

Sanchez-Guerrero J, Liang M, Karlson E, Hunter D, Colditz G . Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus. Ann Intern Med. 1995; 122(6):430-3. DOI: 10.7326/0003-4819-122-6-199503150-00005. View

Sanchez-Guerrero J, Karlson E, Liang M, Hunter D, Speizer F, Colditz G . Past use of oral contraceptives and the risk of developing systemic lupus erythematosus. Arthritis Rheum. 1997; 40(5):804-8. DOI: 10.1002/art.1780400505. View

Hochberg M . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40(9):1725. DOI: 10.1002/art.1780400928. View

Ushiyama T, Ueyama H, Inoue K, Nishioka J, Ohkubo I, Hukuda S . Estrogen receptor gene polymorphism and generalized osteoarthritis. J Rheumatol. 1998; 25(1):134-7. View

Sandborg C . Childhood systemic lupus erythematosus and neonatal lupus syndrome. Curr Opin Rheumatol. 1998; 10(5):481-7. DOI: 10.1097/00002281-199809000-00014. View

Font J, Cervera R, Espinosa G, Pallares L, Ramos-Casals M, Jimenez S . Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis. 1998; 57(8):456-9. PMC: 1752720. DOI: 10.1136/ard.57.8.456. View

Kanda N, Tsuchida T, Tamaki K . Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum. 1999; 42(2):328-37. DOI: 10.1002/1529-0131(199902)42:2<328::AID-ANR16>3.0.CO;2-#. View

Kurabayashi T, Tomita M, Matsushita H, Yahata T, Honda A, Takakuwa K . Association of vitamin D and estrogen receptor gene polymorphism with the effect of hormone replacement therapy on bone mineral density in Japanese women. Am J Obstet Gynecol. 1999; 180(5):1115-20. DOI: 10.1016/s0002-9378(99)70603-4. View

10.

Wilder R, Elenkov I . Hormonal regulation of tumor necrosis factor-alpha, interleukin-12 and interleukin-10 production by activated macrophages. A disease-modifying mechanism in rheumatoid arthritis and systemic lupus erythematosus?. Ann N Y Acad Sci. 1999; 876:14-31. DOI: 10.1111/j.1749-6632.1999.tb07619.x. View

11.

Salmen T, Heikkinen A, Mahonen A, Kroger H, Komulainen M, Saarikoski S . Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy. J Bone Miner Res. 2000; 15(2):315-21. DOI: 10.1359/jbmr.2000.15.2.315. View

12.

Weiderpass E, Persson I, Melhus H, Wedren S, Kindmark A, Baron J . Estrogen receptor alpha gene polymorphisms and endometrial cancer risk. Carcinogenesis. 2000; 21(4):623-7. DOI: 10.1093/carcin/21.4.623. View

13.

Thurmond T, Murante F, Staples J, Silverstone A, Korach K, Gasiewicz T . Role of estrogen receptor alpha in hematopoietic stem cell development and B lymphocyte maturation in the male mouse. Endocrinology. 2000; 141(7):2309-18. DOI: 10.1210/endo.141.7.7560. View

14.

Chang M, Lubahn D, Hoffman R . DNA microsatellite markers for estrogen receptor-beta are not associated with systemic lupus erythematosus. J Rheumatol. 2001; 28(4):924-5. View

15.

Rider V, Jones S, Evans M, Bassiri H, Afsar Z, Abdou N . Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus. J Rheumatol. 2002; 28(12):2644-9. View

16.

Liu Z, Gong R, Liu H, Liu D, Li L . Sex differences in estrogen receptor gene polymorphism and its association with lupus nephritis in Chinese. Nephron. 2002; 90(2):174-80. DOI: 10.1159/000049039. View

17.

Herrington D, Howard T, Hawkins G, Reboussin D, Xu J, Zheng S . Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med. 2002; 346(13):967-74. DOI: 10.1056/NEJMoa012952. View

18.

Stavrou I, Zois C, Ioannidis J, Tsatsoulis A . Association of polymorphisms of the oestrogen receptor alpha gene with the age of menarche. Hum Reprod. 2002; 17(4):1101-5. DOI: 10.1093/humrep/17.4.1101. View

19.

An P, Nelson G, Wang L, Donfield S, Goedert J, Phair J . Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci U S A. 2002; 99(15):10002-7. PMC: 126614. DOI: 10.1073/pnas.142313799. View

20.

Manger K, Repp R, Jansen M, Geisselbrecht M, Wassmuth R, Westerdaal N . Fcgamma receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms. Ann Rheum Dis. 2002; 61(9):786-92. PMC: 1754233. DOI: 10.1136/ard.61.9.786. View